COVID-19 in hematology: data from a hematologic and transplant unit
Fecha
2020Autor
Garnica, Marcia
Rejane Valetim, Marcia
Furtado, Paulo
Moreira, Maria Claudia
Bigni, Ricardo
Vinhas, Simone
Dias, Paulo Cesar
Fellows, Ilza
Martins, Wolney
Documentos PDF
Resumen
During the COVID-19 pandemic, special attention has been addressed in cancer care to mitigate the impact on the patient’s prognosis. We addressed our preparation to face COVID-19
pandemic in a Hematological and Stem Cell Transplant Unit in Brazil during the first two
months of COVID-19 pandemic and described COVID-19 cases in patients and health care
workers (HCW). Modifications in daily routines included a separation of area and professionals, SARS-CoV-2 screening protocols, and others. A total of 47 patients and 54 HCW
were tested for COVID-19, by PCR-SARS-CoV-2. We report 11 cases of COVID-19 in hematological patients (including 2 post stem cell transplant) and 28 cases in HCW. Hematological
cases were most severe or moderate and presented with several poor risk factors. Among
HCW, COVID-19 were mostly mild, and all recovered without hospitalization. A cluster
was observed among HCW. Despite a decrease in the number of procedures, the Transplant Program performed 8 autologous and 4 allogeneic SCT during the period, and 49
onco-hematological patients were admitted to continuing their treatments. Although we
observed a high frequency of COVID-19 among patients and HCW, showing that SARS-CoV2 is disseminated in Brazil, hematological patients were safely treated during pandemic
times
Palabras clave
COVID-19; SARS-CoV-2; Cancer; Stem cell transplant; Health care worker; Pandemic; Cancer careEnlace al recurso
https://doi.org/10.1016/j.htct.2020.08.004Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.